1. Home
  2. PHIN vs ARQT Comparison

PHIN vs ARQT Comparison

Compare PHIN & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHIN
  • ARQT
  • Stock Information
  • Founded
  • PHIN 2023
  • ARQT 2016
  • Country
  • PHIN United States
  • ARQT United States
  • Employees
  • PHIN N/A
  • ARQT N/A
  • Industry
  • PHIN
  • ARQT Biotechnology: Pharmaceutical Preparations
  • Sector
  • PHIN
  • ARQT Health Care
  • Exchange
  • PHIN Nasdaq
  • ARQT Nasdaq
  • Market Cap
  • PHIN 1.7B
  • ARQT 1.7B
  • IPO Year
  • PHIN N/A
  • ARQT 2020
  • Fundamental
  • Price
  • PHIN $48.53
  • ARQT $14.64
  • Analyst Decision
  • PHIN Buy
  • ARQT Strong Buy
  • Analyst Count
  • PHIN 5
  • ARQT 6
  • Target Price
  • PHIN $53.60
  • ARQT $18.80
  • AVG Volume (30 Days)
  • PHIN 388.1K
  • ARQT 1.7M
  • Earning Date
  • PHIN 07-24-2025
  • ARQT 08-13-2025
  • Dividend Yield
  • PHIN 2.24%
  • ARQT N/A
  • EPS Growth
  • PHIN N/A
  • ARQT N/A
  • EPS
  • PHIN 1.75
  • ARQT N/A
  • Revenue
  • PHIN $3,336,000,000.00
  • ARQT $212,819,000.00
  • Revenue This Year
  • PHIN N/A
  • ARQT $61.01
  • Revenue Next Year
  • PHIN $1.58
  • ARQT $37.95
  • P/E Ratio
  • PHIN $27.52
  • ARQT N/A
  • Revenue Growth
  • PHIN N/A
  • ARQT 100.03
  • 52 Week Low
  • PHIN $36.25
  • ARQT $7.86
  • 52 Week High
  • PHIN $57.23
  • ARQT $17.75
  • Technical
  • Relative Strength Index (RSI)
  • PHIN 58.20
  • ARQT 48.94
  • Support Level
  • PHIN $48.01
  • ARQT $15.00
  • Resistance Level
  • PHIN $48.93
  • ARQT $15.78
  • Average True Range (ATR)
  • PHIN 0.94
  • ARQT 0.73
  • MACD
  • PHIN -0.07
  • ARQT -0.02
  • Stochastic Oscillator
  • PHIN 39.64
  • ARQT 44.06

About PHIN PHINIA Inc.

Phinia Inc is engaged in the development, design, and manufacture of integrated components and systems that optimize performance, increase efficiency, and reduce emissions in combustion and hybrid propulsion for commercial vehicles, industrial applications, and light vehicles. Its product portfolio includes alternative fuel systems, fuel delivery modules, evaporative canisters, diesel fuel injection systems, electrical systems, hydrogen solutions, associated software, and others. The company's reportable segments are; the Fuel Systems segment, which derives key revenue, and the Aftermarket segment. Geographically, the company generates maximum revenue from the United States and the rest from the United Kingdom, China, Poland, Romania, Brazil, and other regions.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: